Paul J Mellett - Net Worth and Insider Trading

Paul J Mellett Net Worth

The estimated net worth of Paul J Mellett is at least $997,232 dollars as of 2024-11-13. Paul J Mellett is the Sr. VP, Finance & Admin. & CFO of Enanta Pharmaceuticals Inc and owns about 93,549 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $997,232. Details can be seen in Paul J Mellett's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul J Mellett has not made any transactions after 2023-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Paul J Mellett

To

Paul J Mellett Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul J Mellett owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .

Click here to see the complete history of Paul J Mellett’s form 4 insider trades.

Insider Ownership Summary of Paul J Mellett

Ticker Comapny Transaction Date Type of Owner
ENTA Enanta Pharmaceuticals Inc 2023-12-05 Treasurer and CFO

Paul J Mellett Latest Holdings Summary

Paul J Mellett currently owns a total of 1 stock. Paul J Mellett owns 93,549 shares of Enanta Pharmaceuticals Inc (ENTA) as of December 5, 2023, with a value of $997,232.

Latest Holdings of Paul J Mellett

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENTA Enanta Pharmaceuticals Inc 2023-12-05 93,549 10.66 997,232

Holding Weightings of Paul J Mellett


Paul J Mellett Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul J Mellett has made a total of 4 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 2,412 shares on December 5, 2023, which brought Paul J Mellett around $23,228.

Insider Trading History of Paul J Mellett

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul J Mellett Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul J Mellett Ownership Network

Ownership Network List of Paul J Mellett

No Data

Ownership Network Relation of Paul J Mellett

Insider Network Chart

Paul J Mellett Owned Company Details

What does Enanta Pharmaceuticals Inc do?

Who are the key executives at Enanta Pharmaceuticals Inc?

Paul J Mellett is the Treasurer and CFO of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Sr. VP & Business Dev. Brendan Luu .

Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary

Over the past 18 months, Paul J Mellett made 1 insider transaction in Enanta Pharmaceuticals Inc (ENTA) with a net sale of 2,412. Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 12,479 shares made by Scott T. Rottinghaus , a net sale of 9,391 shares made by Tara Lynn Kieffer , and a net sale of 15,295 shares made by Terry Vance .

In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,756 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,756 shares.

Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enanta Pharmaceuticals Inc Insider Transactions

No Available Data

Paul J Mellett Mailing Address

Above is the net worth, insider trading, and ownership report for Paul J Mellett. You might contact Paul J Mellett via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.